Looking into the subgroup frequencies, we noted that in our group the prevalence of Ikaros deletions among Ph/+/ B-ALL patients is in the lower range of reported figures, while the prevalence in Ph/−/ B-ALL is slightly higher than the previously reported figures. Here, IKZF1 is linked to acute lymphoblastic leukemia.